scispace - formally typeset
A

A. V. Hoffbrand

Researcher at Royal Free Hospital

Publications -  297
Citations -  13634

A. V. Hoffbrand is an academic researcher from Royal Free Hospital. The author has contributed to research in topics: Bone marrow & Antigen. The author has an hindex of 66, co-authored 297 publications receiving 13375 citations. Previous affiliations of A. V. Hoffbrand include Western General Hospital & Northern Hospital.

Papers
More filters
Journal ArticleDOI

Depletion of t lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients

TL;DR: 14 patients were given marrows virtually depleted of identifiable donor marrow T lymphocytes by the use of a "cocktail" of specific anti-T-cell monoclonal antibodies (MBG6 and RFT8) and rabbit complement and GvHD was totally prevented.
Journal ArticleDOI

Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro

TL;DR: This work reports prolonged survival of purified CLL cells cultured on bone marrow (BM) derived stromal cells in the absence of exogenous growth factors and provides an in vitro system that can be used to analyse the growth requirements of C LL cells and their chemosensitivity in an in vivo environment that mimics the in vivo milieu.
Journal Article

Philadelphia positive acute lymphoblastic leukemia in adults: age distribution, BCR breakpoint and prognostic significance.

TL;DR: A fundamental difference between the genetics of ALL in most older and the majority of younger patients may partly explain the increasingly poor prognosis with age.
Journal ArticleDOI

Immune donors can protect marrow-transplant recipients from severe cytomegalovirus infections.

TL;DR: Recipients of seronegative marrow had a fifteen-fold greater risk of CMV pneumonitis and a fifty-fold increase in risk of a fatal CMV infection than recipients of seropositive marrow; whenever possible, such recipients should be given marrow from ser onegative donors.
Journal ArticleDOI

Hepatic iron concentration combined with long‐term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major

TL;DR: The data show that quantitation of liver iron from a single liver biopsy has little value in long‐term monitoring of iron stores, and most complications can be avoided if ferritin levels can be brought down to <1500 μg/l.